Pay in 4 interest-free payments of $23.75 Learn more
Ships within 48 hours · Estimated delivery Jul 28 - Aug 2
potent and selective inhibitor of proteasome-associated deubiquitinating enzymes (DUBs) with favorable toxicity profile and anticancer activity
with an IC50 > 10 uM
InChi: InChI=1S/C21H18O5/c22-20-9-8-16-19(26-20)14-18-17(10-13-24-18)21(16)25-12-5-4-11-23-15-6-2-1-3-7-15/h1-3
OTS514 exhibits growth suppressive effect on small cell lung cancer
BI-D1870 - CAS# 501437-28-1 Catalog No.:M11147-2 potent and selective inhibitor ofBI D1870 is a potent and specific RSK inhibitor (the p90 ribosomal S6 kinase), which inhibits RSK1, RSK2, RSK3 and RSK4 in vitro with an IC50 of 1030 nM. BI D1870 exhibited a dose responsive antiproliferative effect on OSCC cells with relative sparing of normal human oral keratinocytes. The compound inhibited the downstream RSK target YB 1 and caused apoptosis. In addition, BI D1870 also induced G2 M arrest by modulating the expression of p21 and
US$ 119.50
US$ 226.03
US$ 79.00
US$ 99.50
US$ 149.00
US$ 110.25
US$ 103.50
US$ 137.54
US$ 105.00
US$ 92.00
US$ 319.63
US$ 160.00
US$ 126.47
US$ 103.50
US$ 179.50
US$ 197.42
US$ 105.00
US$ 169.00
US$ 396.00